Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2008 Nov;1(3):193–206. doi: 10.1177/1756285608098422

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2008 SAGE Publications

PMC Copyright notice

Figure 2. — Case report: Follow-up of parameters of motor function upon high-dose erythropoietin (EPO) treatment in a right-handed multiple sclerosis (MS) patient with pareses of both upper extremities. (a) motor strength/endurance of the left (nondominant, more severely affected) hand, presented as number of maximum expander grips for every test timepoint; (b) fine motor performance of the left hand, presented as number of threaded pearls over 2 min for every test timepoint. Improvement of the right hand in both tests was similar. Light columns on the left (—14 to 0 weeks) show performance during lead-in/baseline period. Dark columns (1 to 24 weeks) show performance during active-treatment phase. Light columns (25 to 44 weeks) show performance during EPO-free follow-up.